GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD

This study has been completed.
Sponsor:
Information provided by:
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00546624
First received: October 17, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2003
  Estimated Primary Completion Date: No date given